Compare the protective value of metformin against GLP-1s, insulin, and sulfonylureas for glycated hemoglobin (HbA1c) levels, AD development, and mortality; and compare the protective utility of metformin when used in those with DM compared to when used in those without DM for HbA1c levels, AD development, and mortality. The gene discussed is INS; the disease is Alzheimer disease.